Elderly people: propensity to be vaccinated for seasonal influenza in Italy.
Influenza vaccination
comorbidities
elderly
propensity score
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
02 08 2020
02 08 2020
Historique:
pubmed:
11
2
2020
medline:
22
6
2021
entrez:
11
2
2020
Statut:
ppublish
Résumé
Seasonal influenza continues to be a major cause of illness and death. Vaccination is the most cost-effective prophylaxis to prevent the disease and it is particularly important for people who are at high risk of serious complications derived from influenza, especially for people ≥65 years. In Italy, the influenza vaccination program has been unsuccessful with low rates of uptake in people ≥65 years. We analyzed all the community ≥65 years of the Health Promoting Agency (HPA) of Brescia (northern Italy) to evaluate the propensity attitudes toward influenza vaccination among people ≥65 years in four consecutive seasonal influenza campaigns (from 2014/2015 to 2017/2018). Information about subjects were retrieved from administrative databases. Data from 952,822 records were analyzed. The prevalence of vaccinated subjects in the four campaigns was 38.6%, 33.7%, 37.7%, and 40.1%, respectively. Among vaccinated people, the frequencies of individuals aged 65-69.9 years were lower than the frequencies of those in the other age classes, with highest frequencies of vaccinated people in the 75-79.9 years age-class. Overall, males showed a slightly higher propensity to be vaccinated and the propensity toward vaccination increased with age in both genders. Suffering from a chronic disease increased the propensity to vaccination; hypertension had the highest impact on the propensity whereas suffering from vasculopathy has the opposite effect. The value of this study is the possibility to know the factors that might indicate a propensity to get an influenza vaccination and to consider a different approach to people ≥65 years with the characteristics indicating a lower propensity to vaccination.
Identifiants
pubmed: 32040352
doi: 10.1080/21645515.2019.1706931
pmc: PMC7482847
doi:
Substances chimiques
Influenza Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1772-1781Références
Epidemiol Prev. 2008 May-Jun;32(3):137-44
pubmed: 18828551
Vaccine. 2007 Jun 28;25(27):5086-96
pubmed: 17544181
Epidemiol Prev. 2015 Jul-Aug;39(4 Suppl 1):146-58
pubmed: 26499433
MMWR Recomm Rep. 2018 Aug 24;67(3):1-20
pubmed: 30141464
EBioMedicine. 2016 Oct;12:295-301
pubmed: 27658738
J Virol. 2019 Oct 15;93(21):
pubmed: 31391269
Vaccine. 2013 Nov 4;31(46):5339-48
pubmed: 24055351
Health Educ Behav. 2012 Oct;39(5):612-9
pubmed: 22287574
Eur J Health Econ. 2009 May;10(2):227-31
pubmed: 18781347
PLoS One. 2017 Jan 26;12(1):e0170550
pubmed: 28125629
JAMA. 2003 Jan 8;289(2):179-86
pubmed: 12517228